Shares in Value Logo
Product Review Img Vertical

Date : 15/02/2021

Learn why Nanoveu’s (ASX:NVU) Shares surged almost 13% on ASX today

Nanoveu shares surged as much as 13% this morning before we witnessed some selling pressure. The stock price finally settled at $0.068 – representing a 7.94% surge. Nanoveu is an $8 million market cap company that has been very volatile during the pandemic. However, the overall performance has been very close to some of the top growth stocks during the pandemic, with a 36% gain in share price during the past 1 year.

The ASX listed firm, Nanoveu announced this morning that they have signed a 1 year agreement with CuVira Ltd for the exclusive distribution rights of its Nanoshield antiviral products in the United Kingdom. After this announcement was made, NVU’s shares surged up by over 12.698% and is trading at A$0.071 on 15 February 2021.

Nanoveu products can be applied on a lot of surfaces and hence, they are used in mobile phones and digital displays. The Nanoshield products have a coating of copper nanoparticles and hence have antiviral and antimicrobial features. Nanoveu’s deal with CuVira brings a lot of potential for further expansion throughout the region. For Nanoveu, this is not the only commercial agreement that they have in place. Nanoveu already holds several partnership agreements for the commercialisation of its products in Singapore, Malaysia, Thailand, Australia, and New Zealand.

This broadening of horizons will continue into the future and Nanoveu is targeting the B2B channel for its commercialisation, and is also said to be improving the sales potential in the direct-to-consumer channel using its online portal.

Looking for Growth Stocks?

Growth stocks are potentially one of the hardest to pick as there are a lot of factors that need to be considered – from industry tailwinds to financial health of the individual stocks, and a lot of little things in between them. Shares in Value research team have picked their top 3 ASX stocks to buy in 2021. Click here to download the report for free.


Are You Looking To Buy The Best Stocks In 2022?

Stay on top of upcoming market trends. Whether you are a SMSF investor or a young investor we cover a wide range of stocks across all sectors including finance, industrials , real estate , technology, health and biotech etc to give you an edge to invest and trade with an advantage in the ASX listed stocks across large , mid and small caps.

Get stock tips with our Market Experts. We help self-directed investors and self-managed super funds (SMSF) make smarter investment decisions and get better returns. Fill in your details and download your free Report instantly for Top 3 Dividend Stocks to buy in 2022!


Top 5 ASX Stocks to buy in 2022

The hardest part when it comes to finding growth stocks is the ability to understand the finer details of these companies whether its valuations, first mover advantage, assets etc and factors at hand to make an informed decision.

Download your free Report

By downloading this report you agree to the TERMS AND CONDITIONS and our PRIVACY POLICY

Scroll to Top


By submitting this form, I agree to the TERMS AND CONDITIONS and PRIVATE POLICY